Endothelin ET(A) receptor antagonist reverses the inhibitory effect of platelet-derived growth factor on cytokine-induced nitric oxide production

Junichi Hirahashi, Toshio Nakaki, Keiichi Hishikawa, Takeshi Marumo, Matsuhiko Hayashi, Takao Saruta

研究成果: Article査読

4 被引用数 (Scopus)

抄録

Cytokines and cytokine-induced nitric oxide (NO) play important roles in inflammatory glomerular diseases, and both platelet-derived growth factor and transforming growth factor-β inhibit cytokine-induced NO production. In this study, we demonstrated that a selective endothelin ET(A) receptor antagonist, BQ-485 (Hexahydro-1H-azepinylcarbonyl-Leu-d-Trp-d-Trp-OH), reversed the inhibitory effect of platelet-derived growth factor on cytokine-induced NO production, but not that of transforming growth factor-β. Our findings suggest a difference between the inhibitory mechanisms of platelet-derived growth factor and transforming growth factor-β on cytokine-induced NO production. Copyright (C) 1999 Elsevier Science B.V.

本文言語English
ページ(範囲)119-123
ページ数5
ジャーナルEuropean journal of pharmacology
365
1
DOI
出版ステータスPublished - 1999 1月 15

ASJC Scopus subject areas

  • 薬理学

フィンガープリント

「Endothelin ET(A) receptor antagonist reverses the inhibitory effect of platelet-derived growth factor on cytokine-induced nitric oxide production」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル